• The S.O.L.V.E. Health Tech acceleration cycle is open to digital health companies that, if accepted, are willing to commit to partner with us to adapt, test, or launch their products with Medicaid and other vulnerable populations.
• Awardees will have the opportunity to work with S.O.L.V.E. Health Tech to meet their business objectives and, if desired, publish their findings in a peer-reviewed journal. Our sponsors have enabled us to partner with companies for a subsidized rate (subject to the depth of engagement and resources available to the partner company, but likely to range from $10,000 to $50,000 for up to an 18-month partnership). This long-term engagement with S.O.L.V.E. Health Tech will include content adaptation, diverse end user testing, and/or pilot implementation. The judging panel will use discretion during the review process to ensure newer or less well-resourced applicants are not at a disadvantage.
• Willingness to engage in a partnership for up to 18 months. We believe that to generate real, safe changes in healthcare, long-term commitments are key. 
• Companies at all phases of maturity are encouraged to apply.

• Potential impact - is your product poised to address a real health problem?
• Effectiveness - How can your approach to patients be improved to reach the varied cultural and linguistic populations in Medicaid? Is it consistent with the best evidence for effective care for these populations?
• Feasibility - How can your product be best designed for implementation in settings that serve Medicaid populations?
• Acceptability - How will key stakeholders in Medicaid view your product, and how can you drive greater adoption rates?
• Sustainability - How can you build or improve your product to succeed at scale – to go beyond pilots to reach large populations, with integration into work flows, technology, and other aspects of each health care system?

• We will update this page with key dates prior to launching our next cycle.

We offer services across three verticals that enable digital health products to improve their content and implementation strategies so that they reach diverse populations.

• Consultation to adapt products
• Test/ pilot with diverse users
• Validation/ launch in real-world setting

Our previous work demonstrates that S.O.L.V.E. Health Tech’s collaborations between research and industry are effective and impactful. We partnered with Omada Health to adapt their existing diabetes prevention program for underserved patients at high risk of diabetes. This work lasted six months and the results, published in a peer-reviewed journal, were used extensively for further product development and marketing purposes. The collaboration resulted in the adaptation of program curriculum for readability and relevance, feasibility testing in a safety-net population, and program modifications to improve usability based on end-user feedback. See Omada's summary of the collaboration here.

In addition, we conducted acceptability and usability testing of three commercially available mobile applications for diabetes, depression, and caregiving, generating actionable recommendations for application developers to improve the usability of the products for diverse populations.

Currently, S.O.L.V.E. Health Tech is engaged in ongoing partnerships with the HumanDx project, an online platform that leverages collective intelligence and machine learning to improve diagnoses, and Tickit, a patient-facing digital tool that assesses health-related outcomes through literacy- and language-accessible survey formats.